February 21, 2013

Valeant Pharmaceuticals has bought rights to a drug used to treat skin cancer from Eisai, the companies said Thursday.

February 6, 2013

Canadian drug maker Valeant Pharmaceuticals North America announced plans to launch a new sun care line in the spring.

January 11, 2013

Skin care brand CeraVe, developed by Valeant Pharmaceuticals North America, is expanding its portfolio with a line of sun care products slated to hit stores beginning this month.

November 16, 2012

The Federal Trade Commission has approved a deal by Valeant Pharmaceuticals International to buy a Scottsdale, Ariz.-based drug maker.

November 8, 2012

Valeant Consumer Products recently announced that its line of Ocean Saline Nasal Sprays has been the most recommended by pharmacists for 15 years running.

September 25, 2012

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

September 18, 2012

Valeant Pharmaceuticals CFO Howard Schiller has been appointed to the drug maker's board of directors.

September 4, 2012

Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

February 13, 2012

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

February 6, 2012

Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.

January 30, 2012

Valeant Pharmaceuticals said it would not move forward in its pursuit of Ista Pharmaceuticals due to lack of progress.

December 22, 2011

Canadian drug maker Valeant Pharmaceuticals officially owns an Australian drug maker.

December 19, 2011

Drug maker Valeant Pharmaceuticals has launched a hostile takeover bid for ISTA Pharmaceuticals, the company said.

November 11, 2011

A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.

August 18, 2011

Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.

July 15, 2011

Valeant Pharmaceuticals has purchased a dermatology subsidiary from Johnson & Johnson, the Canadian drug maker said Friday.

May 18, 2011

Valeant Pharmaceuticals has announced the launch of the "Change Your Skin, Change Your Life" campaign, in which its Kinerase brand will make three charitable donations in 2011.

March 30, 2011

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 22, 2011

J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.

February 8, 2011

Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

December 20, 2010

Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.

September 1, 2010

Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....

August 30, 2010

The Food and Drug Administration has pushed back its review date for a drug made...

June 22, 2010

Valeant Pharmaceuticals has made a treatment for psoriasis available again, following a shortage, the drug...